Monopar Therapeutics (MNPR) Other Non-Current Assets (2016 - 2021)

Quarterly results put Other Non-Current Assets at $68858.0 for Q3 2021, changed 0.0% from a year ago — trailing twelve months through Sep 2021 was $68858.0 (changed 0.0% YoY), and the annual figure for FY2020 was $68858.0, down 43.73%.

Monopar Therapeutics has reported Other Non-Current Assets over the past 6 years, most recently at $68858.0 for Q3 2021.

  • Other Non-Current Assets reached $68858.0 in Q3 2021 per MNPR's latest filing, roughly flat from $68858.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $800031.0 in Q4 2017 and bottomed at $65731.0 in Q4 2018.
  • Median Other Non-Current Assets over the past 5 years was $70954.0 (2020), compared with a mean of $260660.5.
  • The largest annual shift saw Other Non-Current Assets plummeted 91.78% in 2018 before it surged 86.18% in 2019.
  • Over 5 years, Other Non-Current Assets stood at $800031.0 in 2017, then tumbled by 91.78% to $65731.0 in 2018, then soared by 86.18% to $122381.0 in 2019, then crashed by 43.73% to $68858.0 in 2020, then changed by 0.0% to $68858.0 in 2021.
  • Business Quant data shows Other Non-Current Assets for MNPR at $68858.0 in Q3 2021, $68858.0 in Q2 2021, and $68858.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 12.40 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 60,000.00
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.26 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 2.13 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 63.55 Mn
10 Monopar Therapeutics 466.82 Mn 466.82 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2021 68,858.00
Jun 30, 2021 68,858.00
Mar 31, 2021 68,858.00
Dec 31, 2020 68,858.00
Sep 30, 2020 68,858.00
Jun 30, 2020 73,050.00
Mar 31, 2020 122,381.00
Dec 31, 2019 122,381.00
Dec 31, 2018 65,731.00
Jun 30, 2018 800,031.00
Mar 31, 2018 800,031.00
Dec 31, 2017 800,031.00
Dec 31, 2016 800,393.00